b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Data-Review" Owner="NLM">\n        <PMID Version="1">31912591</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>19</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1530-6860</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>34</Volume>\n                    <Issue>2</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Feb</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</Title>\n                <ISOAbbreviation>FASEB J.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Immune changes in peripheral blood and hematoma of patients with intracerebral hemorrhage.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>2774-2791</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1096/fj.201902478R</ELocationID>\n            <Abstract>\n                <AbstractText>Immunologic changes in the hematoma of patients with intracerebral hemorrhage (ICH) and the contribution of these changes to prognosis are unknown. We collected the blood samples and hematoma fluid from 35 patients with acute ICH (&lt;30 hours from symptom onset) and 55 age-matched healthy controls. Using flow cytometry and ELISA, we found that the percentages of granulocytes, regulatory T cells, helper T (Th) 17 cells, and dendritic cells were higher in the peripheral blood of patients with ICH than in healthy controls, whereas the percentages of lymphocytes, M1-like macrophages, and M2-like macrophages were lower. Levels of IL-6, IL-17, IL-23, TNF-\xce\xb1, IL-4, IL-10, and TGF-\xce\xb2 were higher in the peripheral blood of patients with ICH. The absolute counts of white blood cells, lymphocytes, monocytes, and granulocytes in the hematoma tended to be greater at 12-30 hours than they were within 12 hours after ICH, but the percentage of Th cells decreased in peripheral blood. Increased levels of IL-10 in the serum and hematoma, and a reduction in M1-like macrophages in hematoma were independently associated with favorable outcome on day 90. These results indicate that immunocytes present in the hematoma may participate in the acute-phase inflammatory response after ICH.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2020 Federation of American Societies for Experimental Biology.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Jiang</LastName>\n                    <ForeName>Chao</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Henan, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Yali</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Henan, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hu</LastName>\n                    <ForeName>Qiangfu</ForeName>\n                    <Initials>Q</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Anesthesiology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Shou</LastName>\n                    <ForeName>Jixin</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurosurgery, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhu</LastName>\n                    <ForeName>Li</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Henan, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tian</LastName>\n                    <ForeName>Ning</ForeName>\n                    <Initials>N</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Henan, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sun</LastName>\n                    <ForeName>Lu</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Henan, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Luo</LastName>\n                    <ForeName>Huan</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Henan, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zuo</LastName>\n                    <ForeName>Fangfang</ForeName>\n                    <Initials>F</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Henan, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Li</LastName>\n                    <ForeName>Fangfang</ForeName>\n                    <Initials>F</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Henan, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Yingying</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Henan, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhang</LastName>\n                    <ForeName>Jing</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Henan, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Jiarui</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Winston Churchill High School, Potomac, Maryland.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Jian</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Anatomy, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhang</LastName>\n                    <ForeName>Jiewen</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology, People\'s Hospital of Zhengzhou University, Zhengzhou, P.R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>81301006</GrantID>\n                    <Agency>National Natural Science Foundation of China</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>81671165</GrantID>\n                    <Agency>National Natural Science Foundation of China</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>2018JQ0016</GrantID>\n                    <Agency>Excellent Youth Foundation of Henan Scientific Committee</Agency>\n                    <Country/>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2020</Year>\n                <Month>01</Month>\n                <Day>07</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>FASEB J</MedlineTA>\n            <NlmUniqueID>8804484</NlmUniqueID>\n            <ISSNLinking>0892-6638</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">hematoma</Keyword>\n            <Keyword MajorTopicYN="N">immune changes</Keyword>\n            <Keyword MajorTopicYN="N">intracerebral hemorrhage</Keyword>\n            <Keyword MajorTopicYN="N">outcome</Keyword>\n            <Keyword MajorTopicYN="N">patients</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>09</Month>\n                <Day>27</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>27</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>09</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>9</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>9</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>9</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31912591</ArticleId>\n            <ArticleId IdType="doi">10.1096/fj.201902478R</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Title>REFERENCES</Title>\n            <Reference>\n                <Citation>An SJ, Kim TJ, Yoon BW. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke. 2017;19:3-10.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wang J, Tsirka SE. Contribution of extracellular proteolysis and microglia to intracerebral hemorrhage. Neurocrit Care. 2005;3:77-85.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Feigin VL, Krishnamurthi RV, Parmar P, et al. Update on the global burden of ischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 Study. Neuroepidemiology. 2015;45:161-176.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wang J. Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol. 2010;92:463-477.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lan X, Han X, Li Q, Yang QW, Wang J. Modulators of microglial activation and polarization after intracerebral haemorrhage. Nat Rev Neurol. 2017;13:420-433.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Jiang C, Zuo F, Wang Y, et al. Progesterone exerts neuroprotective effects and improves long-term neurologic outcome after intracerebral hemorrhage in middle-aged mice. Neurobiol Aging. 2016;42:13-24.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wu H, Zhang Z, Hu X, et al. Dynamic changes of inflammatory markers in brain after hemorrhagic stroke in humans: a postmortem study. Brain Res. 2010;1342:111-117.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wu H, Wu T, Xu X, Wang J, Wang J. Iron toxicity in mice with collagenase-induced intracerebral hemorrhage. J Cereb Blood Flow Metab. 2011;31:1243-1250.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Zhu H, Wang Z, Yu J, et al. Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage. Prog Neurobiol. 2019;178:101610.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Hanley DF, Thompson RE, Muschelli J, et al. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. Lancet Neurol. 2016;15:1228-1237.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Li Q, Han X, Lan X, et al. Inhibition of neuronal ferroptosis protects hemorrhagic brain. JCI Insight. 2017;2:e90777.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Zhou Y, Wang Y, Wang J, Anne Stetler R, Yang QW. Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol. 2014;115:25-44.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Zhang Z, Zhang ZE, Lu H, Yang Q, Wu HE, Wang J. Microglial polarization and inflammatory mediators after intracerebral hemorrhage. Mol Neurobiol. 2017;54:1874-1886.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Illanes S, Liesz A, Sun L, Dalpke A, Zorn M, Veltkamp R. Hematoma size as major modulator of the cellular immune system after experimental intracerebral hemorrhage. Neurosci Lett. 2011;490:170-174.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Tapia-Perez JH, Karagianis D, Zilke R, Koufuglou V, Bondar I, Schneider T. Assessment of systemic cellular inflammatory response after spontaneous intracerebral hemorrhage. Clin Neurol Neurosurg. 2016;150:72-79.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Zhou K, Zhong Q, Wang YC, et al. Regulatory T cells ameliorate intracerebral hemorrhage-induced inflammatory injury by modulating microglia/macrophage polarization through the IL-10/GSK3beta/PTEN axis. J Cereb Blood Flow Metab. 2017;37:967-979.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Chang CF, Wan J, Li Q, Renfroe SC, Heller NM, Wang J. Alternative activation-skewed microglia/macrophages promote hematoma resolution in experimental intracerebral hemorrhage. Neurobiol Dis. 2017;103:54-69.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lan XI, Han X, Li Q, et al. Pinocembrin protects hemorrhagic brain primarily by inhibiting toll-like receptor 4 and reducing M1 phenotype microglia. Brain Behav Immun. 2017;61:326-339.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Zhao X, Ting SM, Liu CH, et al. Neutrophil polarization by IL-27 as a therapeutic target for intracerebral hemorrhage. Nat Commun. 2017;8:602.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Hammond MD, Ai Y, Sansing LH. Gr1+ macrophages and dendritic cells dominate the inflammatory infiltrate 12 hours after experimental intracerebral hemorrhage. Transl Stroke Res. 2012;3:s125-s131.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Moxon-Emre I, Schlichter LC. Neutrophil depletion reduces blood-brain barrier breakdown, axon injury, and inflammation after intracerebral hemorrhage. J Neuropathol Exp Neurol. 2011;70:218-235.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wilson D, Seiffge DJ, Traenka C, et al. Outcome of intracerebral hemorrhage associated with different oral anticoagulants. Neurology. 2017;88:1693-1700.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Adachi T, Hoshino H, Takagi M, Fujioka S. Volume and characteristics of intracerebral hemorrhage with direct oral anticoagulants in comparison with warfarin. Cerebrovasc Dis Extra. 2017;7:62-71.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Fiorella D, Arthur A, Bain M, Mocco J. Minimally invasive surgery for intracerebral and intraventricular hemorrhage: rationale, review of existing data and emerging technologies. Stroke. 2016;47:1399-1406.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:2032-2060.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>de Haas AH, Boddeke HW, Biber K. Region-specific expression of immunoregulatory proteins on microglia in the healthy CNS. Glia. 2008;56:888-894.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Szulzewsky F, Schwendinger N, Guneykaya D, et al. Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment. Neuro-Oncology. 2018;20:355-366.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Hjorth E, Zhu M, Toro VC, et al. Omega-3 fatty acids enhance phagocytosis of Alzheimer\'s disease-related amyloid-beta42 by human microglia and decrease inflammatory markers. J Alzheimers Dis. 2013;35:697-713.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Yin Y, Qiu S, Li X, Huang B, Xu Y, Peng Y. EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment. J Neuroinflammation. 2017;14:220.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Peferoen LA, Vogel DY, Ummenthum K, et al. Activation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosis. J Neuropathol Exp Neurol. 2015;74:48-63.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Truettner JS, Bramlett HM, Dietrich WD. Posttraumatic therapeutic hypothermia alters microglial and macrophage polarization toward a beneficial phenotype. J Cereb Blood Flow Metab. 2017;37:2952-2962.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Subramanian S, Pallati PK, Sharma P, Agrawal DK, Nandipati KC. TREM-1 associated macrophage polarization plays a significant role in inducing insulin resistance in obese population. J Transl Med. 2017;15:85.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Jiang C, Kong W, Wang Y, et al. Changes in the cellular immune system and circulating inflammatory markers of stroke patients. Oncotarget. 2017;8:3553-3567.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Law JP, Hirschkorn DF, Owen RE, Biswas HH, Norris PJ, Lanteri MC. The importance of Foxp3 antibody and fixation/permeabilization buffer combinations in identifying CD4+CD25+Foxp3+ regulatory T cells. Cytometry A. 2009;75:1040-1050.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ma Y, Yabluchanskiy A, Iyer RP, et al. Temporal neutrophil polarization following myocardial infarction. Cardiovasc Res. 2016;110:51-61.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Gelderblom M, Leypoldt F, Steinbach K, et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke. 2009;40:1849-1857.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Bramer D, Hoyer H, Gunther A, et al. Study protocol: prediction of stroke associated infections by markers of autonomic control. BMC Neurology. 2014;14:9.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Liotta EM, Prabhakaran S, Sangha RS, et al. Magnesium, hemostasis, and outcomes in patients with intracerebral hemorrhage. Neurology. 2017;89:813-819.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wilson D, Charidimou A, Shakeshaft C, et al. Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type. Neurology. 2016;86:360-366.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Venema E, Mulder M, Roozenbeek B, et al. Selection of patients for intra-arterial treatment for acute ischaemic stroke: development and validation of a clinical decision tool in two randomised trials. BMJ. 2017;357:j1710.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Askenase MH, Sansing LH. Stages of the inflammatory response in pathology and tissue repair after intracerebral hemorrhage. Semin Neurol. 2016;36:288-297.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Yang Z, Yu A, Liu Y, et al. Regulatory T cells inhibit microglia activation and protect against inflammatory injury in intracerebral hemorrhage. Int Immunopharmacol. 2014;22:522-525.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Adeoye O, Walsh K, Woo JG, et al. Peripheral monocyte count is associated with case fatality after intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2014;23:e107-e111.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Yu S, Arima H, Heeley E, et al. White blood cell count and clinical outcomes after intracerebral hemorrhage: The INTERACT2 trial. J Neurol Sci. 2016;361:112-116.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Giede-Jeppe A, Bobinger T, Gerner ST, et al. Neutrophil-to-lymphocyte ratio is an independent predictor for in-hospital mortality in spontaneous intracerebral hemorrhage. Cerebrovasc Dis. 2017;44:26-34.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Easton AS. Neutrophils and stroke-can neutrophils mitigate disease in the central nervous system? Int Immunopharmacol. 2013;17:1218-1225.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Mracsko E, Javidi E, Na SY, Kahn A, Liesz A, Veltkamp R. Leukocyte invasion of the brain after experimental intracerebral hemorrhage in mice. Stroke. 2014;45:2107-2114.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Liu W, Yuan J, Zhu H, et al. Curcumin reduces brain-infiltrating T lymphocytes after intracerebral hemorrhage in mice. Neurosci Lett. 2016;620:74-82.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Rolland WB, Lekic T, Krafft PR, et al. Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage. Exp Neurol. 2013;241:45-55.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Benakis C, Brea D, Caballero S, et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells. Nat Med. 2016;22:516-523.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Zheng Y, Zhong D, Chen H, et al. Pivotal role of cerebral interleukin-23 during immunologic injury in delayed cerebral ischemia in mice. Neuroscience. 2015;290:321-331.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Liu X, Liu J, Zhao S, et al. Interleukin-4 is essential for microglia/macrophage M2 polarization and long-term recovery after cerebral ischemia. Stroke. 2016;47:498-504.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Perez-de Puig I, Miro F, Salas-Perdomo A, et al. IL-10 deficiency exacerbates the brain inflammatory response to permanent ischemia without preventing resolution of the lesion. J Cereb Blood Flow Metab. 2013;33:1955-1966.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Na SY, Mracsko E, Liesz A, Hunig T, Veltkamp R. Amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice. Stroke. 2015;46:212-220.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wang J, Yu L, Jiang C, et al. Cerebral ischemia increases bone marrow CD4+CD25+FoxP3+ regulatory T cells in mice via signals from sympathetic nervous system. Brain Behav Immun. 2015;43:172-183.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Gelderblom M, Weymar A, Bernreuther C, et al. Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood. 2012;120:3793-3802.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Koyasu S, Moro K. Role of innate lymphocytes in infection and inflammation. Front Immunol. 2012;3:101.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Cuartero MI, Ballesteros I, Moraga A, et al. N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARgamma agonist rosiglitazone. Stroke. 2013;44:3498-3508.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ohlsson SM, Linge CP, Gullstrand B, et al. Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization. Clin Immunol. 2014;152:10-19.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Leidi M, Gotti E, Bologna L, et al. M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than M1 cells in vitro. J Immunol. 2009;182:4415-4422.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wang J, Rogove AD, Tsirka AE, Tsirka SE. Protective role of tuftsin fragment 1-3 in an animal model of intracerebral hemorrhage. Ann Neurol. 2003;54:655-664.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wang J, Tsirka SE. Tuftsin fragment 1-3 is beneficial when delivered after the induction of intracerebral hemorrhage. Stroke. 2005;36:613-618.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wang J, Dore S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab. 2007;27:894-908.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wang J, Tsirka SE. Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage. Brain. 2005;128:1622-1633.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Benarafa C, Simon HU. Role of granule proteases in the life and death of neutrophils. Biochem Biophys Res Comm. 2017;482:473-481.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lutz MB. Induction of CD4(+) regulatory and polarized effector/helper T cells by dendritic cells. Immune Netw. 2016;16:13-25.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Zernecke A. Dendritic cells in atherosclerosis: evidence in mice and humans. Arterioscler Thromb Vasc Biol. 2015;35:763-770.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Dieterlen MT, John K, Reichenspurner H, Mohr FW, Barten MJ. Dendritic cells and their role in cardiovascular diseases: a view on human studies. J Immunol Res. 2016;2016:5946807.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Gelderblom M, Leypoldt F, Lewerenz J, et al. The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in mice. J Cereb Blood Flow Metab. 2012;32:835-843.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Hu Y, Zheng Y, Wu Y, Ni B, Shi S. Imbalance between IL-17A-producing cells and regulatory T cells during ischemic stroke. Mediators Inflamm. 2014;2014:813045.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Cai Y, Liu X, Chen W, et al. TGF-beta1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats. Exp Neurol. 2015;266:120-126.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Cherry JD, Olschowka JA, O\'Banion MK. Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation. 2014;11:98.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Poppensieker K, Otte DM, Schurmann B, et al. CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells. Proc Natl Acad Sci USA. 2012;109:3897-3902.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Allam JP, Duan Y, Heinemann F, et al. IL-23-producing CD68(+) macrophage-like cells predominate within an IL-17-polarized infiltrate in chronic periodontitis lesions. J Clin Periodontol. 2011;38:879-886.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Yang J, Ding S, Huang W, et al. Interleukin-4 ameliorates the functional recovery of intracerebral hemorrhage through the alternative activation of microglia/macrophage. Front Neurosci. 2016;10:61.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Krausgruber T, Schiering C, Adelmann K, et al. T-bet is a key modulator of IL-23-driven pathogenic CD4(+) T cell responses in the intestine. Nat Commun. 2016;7:11627.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Luo Y, Zhou Y, Xiao W, et al. Interleukin-33 ameliorates ischemic brain injury in experimental stroke through promoting Th2 response and suppressing Th17 response. Brain Res. 2015;1597:86-94.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Zhao X, Sun G, Zhang J, et al. Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann Neurol. 2007;61:352-362.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Zhao X, Wang H, Sun G, Zhang J, Edwards NJ, Aronowski J. Neuronal interleukin-4 as a modulator of microglial pathways and ischemic brain damage. J Neurosci. 2015;35:11281-11291.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Liang QJ, Jiang M, Wang XH, et al. Pre-existing interleukin 10 in cerebral arteries attenuates subsequent brain injury caused by ischemia/reperfusion. IUBMB Life. 2015;67:710-719.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Fam MD, Zeineddine HA, Eliyas JK, et al. CSF inflammatory response after intraventricular hemorrhage. Neurology. 2017;89:1553-1560.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Sembill JA, Gerner ST, Volbers B, et al. Severity assessment in maximally treated ICH patients: the max-ICH score. Neurology. 2017;89:423-431.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Garcia JM, Stillings SA, Leclerc JL, et al. Role of interleukin-10 in acute brain injuries. Front Neurol. 2017;8:244.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lattanzi S, Cagnetti C, Provinciali L, Silvestrini M. Neutrophil-to-lymphocyte ratio and neurological deterioration following acute cerebral hemorrhage. Oncotarget. 2017;8:57489-57494.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lattanzi S, Cagnetti C, Provinciali L, Silvestrini M. Neutrophil-to-lymphocyte ratio predicts the outcome of acute intracerebral hemorrhage. Stroke. 2016;47:1654-1657.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Taylor RA, Chang CF, Goods BA, et al. TGF-beta1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage. J Clin Investig. 2017;127:280-292.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Cohen M, Matcovitch O, David E, et al. Chronic exposure to TGFbeta1 regulates myeloid cell inflammatory response in an IRF7-dependent manner. EMBO J. 2014;33:2906-2921.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Han Z, Zhao H, Tao Z, et al. TOPK promotes microglia/macrophage polarization towards M2 phenotype via inhibition of HDAC1 and HDAC2 activity after transient cerebral ischemia. Aging Dis. 2018;9:235-248.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Greter M, Lelios I, Croxford AL. Microglia versus myeloid cell nomenclature during brain inflammation. Front Immunol. 2015;6:249.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Kramer AH, Jenne CN, Zygun DA, et al. Intraventricular fibrinolysis with tissue plasminogen activator is associated with transient cerebrospinal fluid inflammation: a randomized controlled trial. J Cereb Blood Flow Metab. 2015;35:1241-1248.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Lan X, Han X, Liu X, Wang J. Inflammatory responses after intracerebral hemorrhage: from cellular function to therapeutic targets. J Cereb Blood Flow Metab. 2019;39:184-186.</Citation>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'